Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03862066 · ClinicalTrials.gov registry record
Memory Phenotype and PD-1 Inhibition Response in Oral Cancer
A clinical trial, sponsored by Medical University of South Carolina.
- Terminated
- Registry status
- 2
- Enrollment target
NCT03862066 is a clinical trial that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 2 participants.
The verdict
NCT03862066 was terminated before completion, sponsored by Medical University of South Carolina.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this research study is collect tissue and blood samples from patients who are having surgery and use those samples in lab studies to see if there are any markers in blood and tissue that can help predict how cancer will react to different treatment. Participants in this study will have a blood sample and tissue samples collected for research. The blood and tissue collected will be tested in the laboratory. The tissue collected will be left over tissue from the standard of care surgery.
Interventions
- OTHER Blood collection
- OTHER Tissue collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2021-11-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03862066
The ClinicalTrials.gov registry entry for NCT03862066 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood collection is the first listed.
NCT03862066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03862066 about?
NCT03862066 is a clinical study titled "Memory Phenotype and PD-1 Inhibition Response in Oral Cancer". The purpose of this research study is collect tissue and blood samples from patients who are having surgery and use those samples in lab studies to see if there are any markers in blood and tissue that can help predict how cancer will react to different treatment. Participants in this study will hav...
What is the current status of trial NCT03862066?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2019-02-08. Estimated completion is 2021-11-22.
What interventions are being tested in trial NCT03862066?
The interventions under investigation include: Blood collection (OTHER), Tissue collection (OTHER).
Who is sponsoring clinical trial NCT03862066?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.